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Abstract 
Covid-19 belongs to the group of corona viruses, morphologically shaped as crown with spikes at the rim, the viral 
spikes being made up of protein S1 and S2. Apart from the ability of SARS Covid-2 (Covid-19) to induce massive 
inflammation in the lungs of infected patients, an additional compounding factor that accompanies the cytokine 
storm is thrombo-embolic phenomenon which has been demonstrated in a number of autopsies/ Haemoptysis as a 
symptom is considered outcome at an outcome of the clotting and haemorrhagic phenomenon. The aim of this 
work is to establish the prevalence of haemoptysis in covid-19 pneumonia as a possible consequence of the 
combined damaging effect of cytokine storm and the thrombo-embolic phenomenon. One hundred and twenty 
Covid-19 patients were selected through record after obtaining ethical clearance/ In no particular order and sticking 
only to random sampling, study group were picked from northeast, northwest and north central geopolitical zones 
of Nigeria. Medical record of each is sorted by by care givers to specifically evaluate the presence of the symptom 
of  haemoptysis at the latter and recovery stage after the sneezing, anosmia and itchy throat early stage and all 
through the stage  where there is cough and deep retrosternal pain in response to the cough with accompanying 
difficulty in breathing. The result indicates the presence of haemoptysis in 10% of PCR Covid-19 confirmed cases 
of pneumonia. 
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INTRODUCTION 
Among the flu causing viruses, like the influenza viruses, the corona viruses have for long been entertained as 
candidates that may possibly assume global spread, a pandemic that may shock the world unlike anything that has 
ever been seen. The covid-19 pandemic, prediction could be said to have come to pass. Even Hollywood movie 
makers for decades have borrowed leaf from these predictions of viral holocaust and made blockbusters that have 
largely affected public opinion. 
What biomedical scientists are postulating is that, this covid-19 pandemic may be the first but certainly not 
the last. More zoonotic attacks and the mutations of the current SARS Covid-2 are frightening prospect and 
realities of the day. 
 Certain viruses are known to have the ability to induce bleeding in diseases and can mostly be classified as 
hemorrhagic fever viruses. Such diseases include lassa fever, Ebola etc. while covid-19 does not belong to this 
category of viruses causing bleeding, the SARS Covid-2 virus has been shown to cause massive and a damaging 
inflammatory reaction through a phenomenon recognized as cytokine storm compounded by the thrombo-embolic 
phenomenon. 
Inflammation is the reaction to injury of the vascular and supporting elements of a living tissue and it is 
characterize by the outpouring of protein-rich exudates. Inflammation functions to limit injury and commences the 
process of healing.  Overwhelming inflammation can be counterproductive as they may cause dysfunction and 
exacerbate further injury, thus in principle warranting the use of anti-inflammatory agents for treatment. Cytokine 
storm has been proposed as one of the mechanism by which Covid-19 phenomenon causes huge damage to the 
lungs and compromise oxygen uptake thus lower percent oxygen saturation of the blood. Hypoxia eventually leads 
to debilitation and death. The ventilation perfusion coefficient gets elevated markedly as a proof. Thrombo-
embolic phenomenon compromises perfusion of the alveoli and is thought be a factor, in part, of the process 
involved in damages and extravasation of blood that may reflect as haemoptysis. 
 
AIM AND OBJECTIVE 
To determine the percentage of PCR Covid-19 +ve patients with SARS Covid-2 pneumonia who have haemoptysis 
as a symptom or sign 
To determine the percentage of those with described earlier with haemoptysis haemoptysis who are over 50 
years of age and above and those who are less than 50 years. 
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MATERIAL AND METHOD 
One hundred and twenty patients suffering from covid-19 were selected using stratified random sampling method, 
20 each from Nigeria’s six geopolitical zones, Northeast, Northwest, North Central, Southeast, South West and 
South-South. The age range for those recruited into the study is from 18 to 80 years The medical information from 
the different approved centers for treatment of Covid-19 were sourced despite the lack of clear cut official policy 
on biomedical research on Covid-19 and the lack of  standby research office dedicated to Covid-19 research related 
activities. The fear, uncertainty, lockdowns and lack of containment facility in virology laboratories have been 
reported to have largely paralyzed research efforts. The medical information obtained for this research was 
simplistic, no name and no center number included. Only the age of the patients, the onset of the symptoms and 
the presence or absence of haemoptysis were recorded along with the percent Oxygen Saturation of Blood 
measured for the patients and the time of its onset of the disease estimated from the time of the initial symptoms. 
TABLE 1 
TABLE OF DISTRIBUTION OF SOME COVID-19 MEDICAL FEATURES WITH PERCENTAGES 
S/N  Total 
number 
Percentages (%) 
1 No of PCR+ve Covid-19 patients with SARS 
Covid-2 Pneumonia 
120  
2 No of PCR +ve Covid-19 patients with SARS 
Covid-2 Pneumonia and Haemoptysis 
22 18% of the 120 Patients 
3 Number of PCR ve+ Covid-19 Patients with SARS 
Covid-2 Pneumonia without Haemoptysis 
98 82% of the 22 patients with SARS 
Covid-2 pneumonia and no 
Haemoptysis. 
4 PCR +ve Covid-19 Patients with SARS Covid-2 
Pneumonia that have Haemoptysis who are  50 
years and above 
17 79% of those with Haemoptysis. 
5 
 
PCR +ve Covid-19 Patients with SARS covid-2 
Pneumonia that have Haemoptysis who are below 
50 years  
5 21% 
 
BAR CHART SHOWING THE DISTRIBUTION OF SOME COVID-19 MEDICAL FEATURES WITH 
PERCENTAGES 
 
FIGURE I  
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Viruses are a force of nature capable of affecting the biology of their host cells. While the microbial world in 
Endowed with certain proteins capable of inducing allergy, others affect haemostasis possibly through interaction 
with platelet factor 4 (PF4) that may precipitate clot formation and ultimately bleeding. 
The results from this work show that 18% of the PCR +ve Covid-19 patients with SARS Covid-2 pneumonia 
were found to have associated haemoptysis, a feature possibly due to thrombo-embolic phenomenon. Covid-19 
coagulopathy has made it to the medical literature and it has become a reference a phenomenon used in explaining 
some features of the disease like the clinically significant lowering of the percent Oxygen saturation measured in 
the invasively ventilated patients (Zagrillo et al 2020). The ensuring hypoxia may explain the extreme lethargy 
and debilitation that lead to deaths. 
PCR +ve Covid-19 Patients with SARS Covid-2 Pneumonia that have Haemoptysis and are  50 years and 
above are represented as 79%.This suggests  that older age represent an increase vulnerability to development of 
haemoptsis in PCR +ve Covid-19 patients with SARS Covid-2 pneumonia. Pre-existing conditions in old age have 
been indicated in cases with Covid-19 as bad prognostic factor. With advancing age the immune functions are 
progressively less efficient and the tendency for allergies and other forms of biological over-reactities become 
even prevalent. It also translates to the fact that younger individual have less tendency to develop the like of 
cytokine storm and the thrombo-embolic phenomenon. 
 
CONCLUSION: 
The understanding of the pathophysiology of the PCR +ve SARS Covid-2 pneumonia is key to developing efficient 
management protocol and limiting the death rate in this pandemic. A broader understanding will add to 
preparedness for a possible future pandemic disease of infectious viral induced Flu with the like of the mortality 
like that of Covid-19. Multiple and more expanded studies may be enormous help.  
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